Xconomy

NOVEMBER 13, 2019

Another of the biopharma startups created as part of a collaboration between San Diego investment firm Avalon Ventures and GlaxoSmithKline has been acquired—but not by GSK. Debuting in COI (which stands for “community of innovation”). Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Avalon 73

Avalon San Diego Incubator Invest 73

socalTECH

SEPTEMBER 23, 2014

San Diego-based venture capital investor Avalon Ventures and biopharmaceuticals firm GlaxoSmithKline said Monday that the two have teamed up to fund and launch up to 10, early stage life science companies. According to Avalon Ventures and GSK, they will provide up to $495M to fund those ten new companies. READ MORE>>.

Avalon 100

Avalon San Diego Startup Venture Capital 100

socalTECH

JANUARY 17, 2011

San Diego-based venture capital firm Avalon Ventures has boosted an Internet web site publisher known for its humorous, captioned pictures of cats and use of Internet memes, Cheezburger. Other investors in the company include Foundry Group, Madrona Ventures, and SoftBank Capital.

Avalon 160

Avalon Sites Funding San Diego 160

socalTECH

JANUARY 10, 2011

San Diego-based Avalon Ventures , a venture capital firm focused on early stage high tech, digital media, and life sciences firms, said today that it has closed on $200M in capital commitments for its latest fund. Avalon said that the fund, Avalon Ventures IX, LP, is the ninth and largest fund for the company.

Avalon 140

Avalon Funding High Tech San Diego 140

socalTECH

SEPTEMBER 14, 2015

La Jolla-based venture capital investor Avalon Ventures has just received a $103M commitment to a new, $300M fund, according to a regulatory filing by the firm. Avalon invests in both life sciences and technology companies, and invests in seed an dearly stage companies. READ MORE>>.

Avalon 100

Avalon Funding Venture Capital Invest 100

socalTECH

DECEMBER 2, 2010

San Diego-based venture capital firm Avalon Ventures has led an investment in a cloud computing company, Standing Cloud , based in Boulder, Colorado. According to Standing Cloud, it received a $3M, Series B financing from Avalon, which also included the firm's prior investor, The Foundry Group.

Avalon 154

Avalon Invest Cloud Computing San Diego 154

socalTECH

MARCH 15, 2012

San Diego-based Avalon Ventures , one of the venture capital investors in social gaming phenomenon Zynga , may be set to cash in on its shares of the newly public gaming firm, after Zynga said this week that it is planning a $400M, secondary offering of its stock.

Avalon 150

Avalon SoCal Southern California San Diego 150

socalTECH

JULY 1, 2011

Among the investors who may benefit from a successful IPO are La Jolla-based Avalon Ventures , run by Kevin Kinsella, Stephen Tomlin, Richard Levandov, Brady Bohrmann, Doug Downs and Jay Lichter, which before the IPO owned 6.1 Katzenberg sits on the company's board. percent of Zynga. READ MORE>>.

Avalon 140

Avalon Southern California Class Marketing 140

socalTECH

JUNE 11, 2021

The company begins trading this morning on the Nasdaq Global market under the ticker symbol JANX. According to the company, the gross proceeds from the effort are expected to be $193.8M. Janux Therapeutics is developing T cell engager immunotherapies.

Pricing 113

Pricing Avalon Capital Marketing 113

socalTECH

JULY 13, 2020

La Jolla-based Nerio Therapeutics , a new, stealth-mode company in the life sciences sector, has raised $3.0M It's unclear what Nerio Therapeutics may be working on, but the fourth officer of the company listed in the filing appears to be Dr. Stefan Heller, a faculty member at Stanford and a developmental neurobiologist.

Avalon 113

Avalon Incubator Funding Company 113

socalTECH

MARCH 31, 2020

The funding was led by Cigna Ventures and MemorialCare Innovation Fund (MCIF), and also included Avalon Ventures, CU Healthcare Innovation Fund and Stanford Health Care. The company said the funding will go to towards accelerating expansion of its platform across the country.

Funding 140

Funding Avalon San Diego Platform 140

Xconomy

SEPTEMBER 27, 2016

[ Note: The headline has been corrected to better describe the company’s type of funding. San Diego’s Avalon Ventures led the Series A round, and has established Fortis at COI Pharma, the firm’s biotech incubator (which now houses 16 life sciences startups). 9/27/16, 2:09 p.m. Bregua Corp.,

Avalon 40

Avalon Funding Startup San Diego 40

socalTECH

MARCH 29, 2021

San Diego-based Fortis Therapeutics, a biotechnology startup developing treatments for late-stage prostate cancer and multiple myeloma, has raised $40M in a Series A financing, the company said on Monday.

Avalon 113

Avalon San Diego Research Funding 113

socalTECH

JULY 28, 2020

San Diego-based telemedicine and telehealth software developer AristaMD has added another $6M to the company's Series B, bringing the total to $24M, the company said on Monday. The company is led by CEO Brooke LeVasseur. The funding came from Ascension Ventures and.406 The funding came from Ascension Ventures and.406

Funding 100

Funding Avalon San Diego Software Development 100

socalTECH

NOVEMBER 13, 2019

San Diego-based COI Pharmaceuticals , the life sciences incubator and support entity created by Avalon Ventures to support its portfolio companies, says that one of its companies, Calporta Therapeutics , has been acquired by Merck. The deal is worth up to $576M, including upfront payments and contingent milestone payments.

Avalon 124

Avalon San Diego Incubator Technology 124

socalTECH

NOVEMBER 22, 2013

San Diego-based Avalon Ventures announced this morning that it has launched a new company, Sitari Pharmaceuticals , with $10M in a Series A financing. READ MORE>>. disease celiac lifescience biotech capital venture glaxosmithkline pharmaceuticals sitary ventures avalong'

Avalon 153

Avalon San Diego Capital Funding 153

socalTECH

APRIL 17, 2017

Gorman is the CEO of Neurocrine Biosciences, where he has been since 1993; he previously was an investor at Avalon Medical Partners, L.P. who the company said will not stand for re-election to its board. Monrovia-based biopharmaceuticals developer Xencor announced this morning that it has named Kevin Gorman, ph.D., READ MORE>>.

Avalon 113

Avalon Monrovia Develop Development 113

socalTECH

SEPTEMBER 15, 2014

It looks like the peer-to-peer marketplace for rides in Los Angeles is about to get a lot hotter, as one of the companies competing in the market-- Sidecar said this morning that it has raised $15M more in funding. Avalon Ventures is also based in San Diego. Avalon Ventures is also based in San Diego. READ MORE>>.

Avalon 153

Avalon San Diego Venture Capital Mobile 153

socalTECH

AUGUST 19, 2019

San Diego-based ScoreStream , which provides crowdsourced, local sports scores, photos, videos, and more for high school football and other teams, is connecting with Amazon Alexa, the company said on Friday. ScoreStream is led by CEO and co-founder Derrick Oien, and previously has raised venture funding from Intel Capital and Avalon Ventures.

Avalon 100

Avalon San Diego Capital Funding 100

Xconomy

SEPTEMBER 11, 2019

GlaxoSmithKline is acquiring a startup it helped launch in 2013 as part of an alliance with life sciences venture capital firm Avalon Ventures. Avalon said Tuesday that GSK (NYSE: GSK ) has agreed to buy the company, Sitari Pharmaceuticals, which has been developing a treatment for celiac disease.

Avalon 56

Avalon Invest Develop Development 56

socalTECH

JULY 14, 2017

StackIQ was venture backed by Anthem Venture Partners, Grayhawk Capital, Avalon Ventures, and crowdfunding site OurCrowd. According to Teradata, the deal also includes StackIQ's team of engineers, who will join the company's R&D organization. Financial terms of the acquisition were not announced. READ MORE>>.

Avalon 113

Avalon Anthem San Diego Acquisition 113

socalTECH

JANUARY 9, 2014

San Diego-based Avelas Biosciences announced today that it has raised $6.85M in a Series B funding round, for the company''s technology for illuminating cancer cells. The company said the funding came from Avalon Ventures, and also included Torrey Pines Investment, WuXi AppTec, and an additional, un-named investor. READ MORE>>.

Avalon 138

Avalon San Diego Funding Capital 138

socalTECH

SEPTEMBER 27, 2016

San Diego-based Fortis Therapeutics , a new biotech company in the immuno-oncology area, announced this morning that it has raised $18M in a Series A funding. The funding was led by Avalon Ventures and also included Bregua Corporation, Lilly Asia Ventures, Osage University Partners, and Vivo Capital.

Avalon 100

Avalon San Diego Research Capital 100

socalTECH

OCTOBER 22, 2014

San Diego-based StackIQ , which develops IT automation tools for the enterprise, has raised $6M in a Series B funding round, according to the company. The new funding came from Grayhawk Capital, Keshif Ventures, DLA Piper, and OurCrowd, as well as Anthem Venture Partners and Avalon Ventures. The company is led by Tim McIntire.

Avalon 174

Avalon Anthem San Diego Venture Capital 174

socalTECH

MARCH 5, 2013

Carolus Therapeutics is venture backed by Avalon Ventures, and is headed by Court Turner, who is both CEO of Carolus and a venture partner at Avalon. Terms of the debt funding were not announced by the companies. According to Square 1, the new funding will go support future growth at Carolus. READ MORE>>.

Avalon 147

Avalon Funding San Diego Develop 147

socalTECH

FEBRUARY 5, 2014

The company is offering up 3,529,411 shares of its stock, and plans to trade on the NASDAQ Global Market as INGN. Inogen is venture backed by Novo AS, Versant Ventures, Arborteum Ventures, Avalon Ventures, and Accuitive Medical Ventures. and $18.00 READ MORE>>. inogen merger acquisition exist medical equipment lifescience ingn'

Avalon 214

Avalon Pricing Acquisition Marketing 214

socalTECH

AUGUST 18, 2016

San Diego-based biopharmaceuticals developer Avelas Biosciences has raised $20M in a Series C funding, according to the company. and laos included Ervington Investments Limited and Alexandria Venture Investments plus Avalon Ventures, Bregua Corporation, and WuXi Healthcare Ventures. Andrei Petrov, Ph.D.,

Avalon 100

Avalon San Diego Invest Funding 100

socalTECH

SEPTEMBER 10, 2014

The second tranche of the company''s Series B came from investors Avalon Ventures, Torrey Pines Investment and WuXi PharmaTech Investments. San Diego-based Avelas Biosciences , which is developing cell penetrating peptides to light up cancerous tissue in patients during surgery, has raised $7.4M in a Series B funding.

Avalon 147

Avalon San Diego Venture Capital Research 147

socalTECH

JULY 20, 2016

The funding was led by RA Capital Management, and also included Avalon Ventures and Correlation Ventures. RA Capital Management's Andrew Levin joins the company's board with the funding. The company's technology is based on research from The Scripps Research Institute.

Avalon 100

Avalon San Diego Research Capital 100

socalTECH

NOVEMBER 28, 2016

Synthorx is focused on developing novel protein therapeutics, and is venture backed by RA Capital Management, Avalon Ventures and Correlation Ventures. The company announced a funding round in July. READ MORE>>.

Avalon 100

Avalon San Diego Capital Funding 100

socalTECH

JANUARY 26, 2017

AnaptysBio is backed by Frazier Healthcare, Novo A/S, Avalon Ventures, Alloy Ventures, Biotechnology Value Fund, HBM Healthcare Investments, and others. The company now trades as ANAB on the NASDAQ Global Select Market. Anaptys priced its IPO on Wednesday night at $15.00 per share, at the midpoint of its $14.00 READ MORE>>.

Avalon 100

Avalon San Diego Pricing Invest 100

socalTECH

AUGUST 13, 2014

The company was trading around $17.52 The company raised $100M in the IPO. The company priced at the high end of its initial estimated IPO range, which was $14.00 The company is developing treatments for disorders of the inner ear. million shares of its common stock at $16.00 per share last night.

Avalon 138

Avalon San Diego Pricing Acquisition 138

socalTECH

AUGUST 4, 2014

The company indicated in a filing that it now expects its IPO at between $14.00 The company is venture backed by Avalon Ventures, OrbiMed, Novo AS, TPG Biotech, Domain Associates, Rivervest Venture Partners, as well as others. and $16.00 Otonomy has applied to list on the NASDAQ Global Market as OTIC. READ MORE>>.

Pricing 147

Pricing Avalon San Diego Acquisition 147

socalTECH

JANUARY 17, 2017

The company is selling 4,000,000 shares of its common stock on the NASDAQ Global Select Market as ANAB. AnaptysBio is backed by Frazier Healthcare, Novo A/S, Avalon Ventures, Alloy Ventures, Biotechnology Value Fund, HBM Healthcare Investments, and others. and $16.00 as early as Thursday.

Pricing 100

Pricing Avalon Southern California Venice 100

socalTECH

APRIL 30, 2014

San Diego-based biopharmaceuticals developer Otonomy --which is developing treatments for inner and middle ear disorders--has roped in a big, $49M funding, the company announced this morning. The company said the new funding will go towards its product pipeline and a potential filing for regulatory approval of its lead compound.

Funding 138

Funding Avalon San Diego Capital 138

socalTECH

MAY 9, 2014

The startup--which is backed by Avalon Ventures--operates a financial service which lets consumers in the U.S. The company says it has raised over $3M in venture funding in total so far. San Diego-based Quippi said this week that it has expanded its list of partners in Mexico. READ MORE>>.

Avalon 174

Avalon San Diego Services Funding 174

socalTECH

DECEMBER 2, 2013

The company''s IPO is being underwritten by J.P. Inogen is venture backed by Novo A/S, Versant Ventures, Arboretum Ventures, Avalon Ventures, AMV Partners, and others. Morgan, Leerink Swann, William Blair, and Stifel. READ MORE>>. inogen merger acquisition copd ingn portable oxygen concentrator lifescience medical device'

Avalon 153

Avalon Acquisition Marketing Develop 153